腺二酸盐-核糖化极大地影响蛋白质的功能:关注神经退行性疾病
Chaowen Huang1, Huilin Xiao2, Yang Yang3
1Department of Respiratory Medicine, Jiangmen Central Hospital Affiliated Jiangmen Hospital of Sun Yat-sen University, Jiangmen, China.
Frontiers in aging neuroscience
|May 15, 2025
概括
腺二酸盐-核糖化 (ADPRylation) 影响细胞过程和神经退行性疾病 (NDs). 向多PADP-ribose聚合酶 (PARP) 为NDs提供了治疗潜力,尽管面临挑战.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 神经科学是一个神经科学.
背景情况:
- 腺二酸盐-核糖化 (ADPRylation) 是一个重要的翻译后修饰,调节细胞功能.
- 聚 ((ADP-ribose) 聚合酶 (PARP) 催化ADPRylation,影响DNA修复,炎症和疾病.
- 失调的ADPRylation与神经退行性疾病 (NDs) 的病原发生有关.
研究的目的:
- 审查ADPRylation和PARP在神经退行性疾病中的作用.
- 突出ADPRylation在NDs中的蛋白质聚合和细胞信号传递中的参与.
- 讨论针对ND的ADPRylation治疗潜力和挑战.
主要方法:
- 关于神经退行症中ADPRylation和PARP的最新发现的文献综述.
- 分析ADPRylation在蛋白质聚合,神经炎症和代谢功能障碍中的作用.
- 评估PARP抑制剂的影响和临床翻译挑战.
主要成果:
- ADPRylation是各种生理和病理过程的关键调节者,包括NDs.
- 在ND模型中,PARP抑制剂显示出缓解神经炎症,氧化应激和代谢功能障碍的潜力.
- 诸如血脑屏障透不良和细胞特异性反应等挑战阻碍了临床应用.
结论:
- 在神经元细胞和神经退行过程中,ADPRylation起着重要的作用.
- 针对ADPRylation通路的向调节为NDs的精密疗法提供了一个有希望的途径.
- 需要进一步的研究来克服ADPRylation向治疗的临床翻译障碍.
相关概念视频
RNA Editing
8.8K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
8.8K
Phosphorylation
49.6K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
49.6K
Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K
Riboswitches
8.0K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.0K
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
Drugs Affecting Neurotransmitter Synthesis
1.2K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.2K


